Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Review: Menstrual migraine: therapeutic approaches
Therapeutic Advances in Neurological Disorders, 09/02/09
MacGregor EA – Although few therapeutic trials have yet been undertaken in accordance with the criteria, the results of those published to date confirm the efficacy of acute migraine drugs for symptomatic treatment. If this approach is insufficient, the predictability of attacks provides the opportunity for perimenstrual prophylaxis. Continuous contraceptive strategies provide an additional option for management, although clinical trial data are limited. Future approaches to treatment could explore the genomic and nongenomic actions of sex steroids.
Related Articles
Menstrual migraine pattern may start in adolescence
Internet Source, 11/12/09
Relevance Score: 70%
Menstrual migraine pattern may start in adolescence
Internet Source, 11/10/09
Relevance Score: 68%
Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis
Headache: The Journal of Head and Face Pain, 10/15/09
Relevance Score: 68%
Increased Dopamine Is Associated With the cGMP and Homocysteine Pathway in Female Migraineurs
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 64%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 48%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip
Arthritis Research & Therapy, 12/14/09
Effect of implanting fibrin sealant with ropivacaine on pain after laparoscopic cholecystectomy
World Journal of Gastroenterology, 12/14/09
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


